A RELIABILITY STUDY OF SLEDAI - A DISEASE-ACTIVITY INDEX FOR SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：0

作者：

HAWKER, G

GABRIEL, S

BOMBARDIER, C

GOLDSMITH, C

CARON, D

GLADMAN, D

机构：

[1] WELLESLEY COLL HOSP, DEPT MED, DIV RHEUMATOL, TORONTO M4Y 1J3, ONTARIO, CANADA

[2] MAYO CLIN & MAYO FDN, DEPT MED, DIV RHEUMATOL, ROCHESTER, MN 55905 USA

[3] MCMASTER UNIV, DEPT CLIN EPIDEMIOL & BIOSTAT, HAMILTON L8S 4L8, ONTARIO, CANADA

[4] WELLESLEY COLL HOSP, CLIN EPIDEMIOL UNIT, TORONTO M4Y 1J3, ONTARIO, CANADA

来源：

JOURNAL OF RHEUMATOLOGY | 1993年 / 20卷 / 04期

关键词：

LUPUS DISEASE ACTIVITY; SLEDAI; OUTCOME MEASURES;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SLEDAI, a disease activity index for systemic lupus erythematosus (SLE) has been validated against other such indices and its reliability has been shown by specialists in SLE. To assess its reliability among less experienced clinicians, we conducted a reliability study 3 rheumatology trainees and 9 patients with SLE according to a Latin square design. SLEDAI easily distinguished between patients (p = 0.0009), and physician variability was not statistically significant (p = 0.27). Inter and intraobserver agreement were 78.7 and 98.0%, respectively. SLEDAI was thus shown to be a reliable instrument among less experienced observers for the assessment of disease activity in SLE.

引用

页码：657 / 660

页数：4

共 50 条

[31] Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis
Du, Y.
Wu, X.
Chen, M.
Wang, W.
Xv, W.
Ye, L.
Wu, D.
Xue, J.
Sun, W.
Luo, J.
Wu, H.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2017, 188 (02) : 234 - 242
[32] Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus
Parodis, Ioannis
Johansson, Petter
Gomez, Alvaro
Soukka, Sofia
Emamikia, Sharzad
Chatzidionysiou, Katerina
RHEUMATOLOGY, 2019, 58 (12) : 2170 - 2176
[33] Immunological Studies of Reactive Oxygen Species Damaged Catalase in Patients with Systemic Lupus Erythematosus: Correlation with Disease Activity Index
Al-Shobaili, Hani A.
Al Robaee, Ahmad A.
Alzolibani, Abdullateef A.
Rasheed, Zafar
IMMUNOLOGICAL INVESTIGATIONS, 2013, 42 (03) : 191 - 203
[34] Clinical significance of peripheral nervous system involvement in systemic lupus erythematosus patients: Relation to disease activity and damage index
Niazy, Marwa H.
Fakhry, George N.
Fawzy, Samar M.
EGYPTIAN RHEUMATOLOGIST, 2023, 45 (02) : 177 - 181
[35] Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians
Chang, E
Abrahamowicz, M
Ferland, D
Fortin, PR
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (05) : 488 - 497
[36] The spectrum of nasal involvement in systemic lupus erythematosus and its association with the disease activity
Kusyairi, K. A.
Gendeh, B. S.
Sakthiswary, R.
Shaharir, S. S.
Haizlene, A. H.
Yusof, K. H.
LUPUS, 2016, 25 (05) : 520 - 524
[37] Major depression and disease activity among systemic lupus erythematosus Egyptian females
Raafat, Hala Ahmed
El Refai, Rasha M.
Alrasheed, Heshmat A.
El Din, Mohamed Nasr
EGYPTIAN RHEUMATOLOGIST, 2015, 37 (04) : S1 - S6
[38] Systemic lupus erythematosus with high disease activity identification based on machine learning
Da-Cheng Wang
Wang-Dong Xu
Zhen Qin
Lu Fu
You-Yu Lan
Xiao-Yan Liu
An-Fang Huang
Inflammation Research, 2023, 72 : 1909 - 1918
[39] Influenza virus vaccination of patients with systemic lupus erythematosus: Effects on disease activity
Abu-Shakra, M
Zalmanson, S
Neumann, L
Flusser, D
Sukenik, S
Buskila, D
JOURNAL OF RHEUMATOLOGY, 2000, 27 (07) : 1681 - 1685
[40] Systemic lupus erythematosus with high disease activity identification based on machine learning
Wang, Da-Cheng
Xu, Wang-Dong
Qin, Zhen
Fu, Lu
Lan, You-Yu
Liu, Xiao-Yan
Huang, An-Fang
INFLAMMATION RESEARCH, 2023, 72 (09) : 1909 - 1918

← 1 2 3 4 5 →